AIDX20/20 Biolabs, Inc.vs its industry peers
A metric-by-metric comparison of 20/20 Biolabs, Inc. against Services-Testing Laboratories — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
Full peer comparison
Peers: same SEC industry (Services-Testing Laboratories)| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIDXThis | $6M#3 | — | 2.4x#3 | 3.0x#3 | 16.7%#1 | 32.7%#1 | -162.9%#4 | -146.5%#4 | — | — | — | — |
| BNBX | $2M#4 | 0.0x#1 | 0.2x#1 | 1.1x#1 | 1.1%#5 | -116.8%#4 | -750.9%#5 | -121.2%#3 | -135.1%#3 | — | -93.5%#3 | — |
| FUNI | — | — | — | — | 7.8%#3 | -294.9%#5 | -111.2%#3 | — | — | — | — | — |
| NEO | $1.8B#2 | — | 2.2x#2 | 2.5x#2 | 10.1%#2 | -36.7%#3 | -15.9%#2 | -13.0%#2 | -11.3%#2 | 4#1 | 87.9%#1 | — |
| ULS | $17.5B#1 | 50.6x#2 | 13.3x#4 | 5.7x#4 | 6.4%#4 | -0.3%#2 | 17.1%#1 | 24.6%#1 | 27.0%#1 | — | 22.4%#2 | 0.6%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 8734). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice